这是首次针对这种情况的独立疗法,当标准疗法无法改善抑郁症状时就会发生这种情况。Spravato之前在美国被批准用于口服抗抑郁药治疗难治性抑郁症以及患有自杀念头的抑郁症患者。据估计,美国2100万患有严重抑郁症的成年人中,约有三分之一对治疗无效。这项新的批准为患者提供了更多的治疗选择自由。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.